Correlation Between Cue Biopharma and Verona Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and Verona Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and Verona Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and Verona Pharma PLC, you can compare the effects of market volatilities on Cue Biopharma and Verona Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of Verona Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and Verona Pharma.

Diversification Opportunities for Cue Biopharma and Verona Pharma

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between Cue and Verona is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and Verona Pharma PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verona Pharma PLC and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with Verona Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verona Pharma PLC has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and Verona Pharma go up and down completely randomly.

Pair Corralation between Cue Biopharma and Verona Pharma

Considering the 90-day investment horizon Cue Biopharma is expected to under-perform the Verona Pharma. In addition to that, Cue Biopharma is 2.2 times more volatile than Verona Pharma PLC. It trades about -0.01 of its total potential returns per unit of risk. Verona Pharma PLC is currently generating about 0.13 per unit of volatility. If you would invest  1,367  in Verona Pharma PLC on September 2, 2024 and sell it today you would earn a total of  2,596  from holding Verona Pharma PLC or generate 189.9% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Cue Biopharma  vs.  Verona Pharma PLC

 Performance 
       Timeline  
Cue Biopharma 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Cue Biopharma are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Cue Biopharma exhibited solid returns over the last few months and may actually be approaching a breakup point.
Verona Pharma PLC 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Verona Pharma PLC are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Verona Pharma sustained solid returns over the last few months and may actually be approaching a breakup point.

Cue Biopharma and Verona Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cue Biopharma and Verona Pharma

The main advantage of trading using opposite Cue Biopharma and Verona Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, Verona Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verona Pharma will offset losses from the drop in Verona Pharma's long position.
The idea behind Cue Biopharma and Verona Pharma PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
CEOs Directory
Screen CEOs from public companies around the world
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments